(Q80291368)
Statements
Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy (English)
Takatsugu Okegawa
Manami Kinjo
Kikuo Nutahara
Eiji Higashihara
1 September 2006